#1 out of 9841.9M est. views8.57%
politics12h ago
Donald Trump reclassifies Marijuana
Vt.co and 20 more
- The DOJ moved state-licensed medical marijuana and FDA-approved products to Schedule III, signaling lower risk and broader research possibilities.
- The rescheduling frames medical marijuana as lower risk, potentially expanding research and treatment options with tax implications for businesses.
- A fast-track federal registration pathway with the DEA is created by integrating state licensing into the federal framework.
Vote 41








